Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Article: The Patient Abroad

    April 2, 2015 |  

    Published in Medical Marketing & Media March 2015

    Approximately 11 million people were medical tourists in 2013, generating a market worth over $50 billion. While obtaining accurate data is challenging, estimates suggest the global medical tourism market is expanding by 25% each year.

    Having grown up in the UK, where high-quality healthcare is available to all through the National Health Service, I hadn’t given the concept of medical tourism a great deal of thought before I moved to Asia. It would simply not have occurred to me to seek healthcare overseas for any other reason than if I happened to fall ill while traveling. 

    I first became aware of the concept when reading rumors that Zimbabwe’s President Robert Mugabe was being treated in one of Singapore’s exclusive private hospitals – which happened to be just down the road from my apartment at the time. This led to much discussion among my peers about how much it would cost to be a medical tourist in Singapore. “High end” patients can expect to accrue bills of thousands of dollars. The most expensive “hospitel” (hospital hotel) penthouse suite (not room) in Singapore costs over $8,000 per night – and it does not include the additional costs of medical treatment. This particular establishment anticipates that at least half of its “guests” (not patients) will come from overseas.

    Read the full article on Medical Marketing & Media »

    This content was provided by Inizio

    Company Details

    - PMLiVE

    Inizio

    Email
    Website

     Latest Content from  Inizio 

    Eliminating Stigma: A consideration of the role the pharmaceutical industry can play

    My recent article in Medical Marketing & Media explored the importance of vaccine perceptions in a self-pay market and touched upon the issue of stigma, with the recognition that some diseases or...

    Fighting talk

    One thing that grasps my interest is how society has adopted military style language when talking about cancer

    Is MINT the next BRIC?

    In 2001, British economist Jim O’Neill coined the now ubiquitous acronym ‘BRIC’, to stand for the four emerging economies of Brazil, Russia, India and China, which he suggested were all...

    The healthcare market research themes for 2014

    As we shake off our winter coats and prepare for what will hopefully be a long, hot summer, the 2014 themes for healthcare and market research are emerging.

    Big Data—a new player in the Healthcare Industry

    Big Data is an exciting by-product of the information technology revolution and offers new ways of understanding customers.

    Blog: Affordable Care Act

    What does the future hold for the US pharma industry?

    Webinar: How to conduct effective market research in emerging markets

    Pharmaceutical market research is still evolving in many emerging markets and so finding the insights you require can be a challenge.

    Webinar: Uncovering hidden insights into patient compliance

    Pharma companies are increasingly looking for ways to provide “beyond the pill" services to support patients with the management of their disease. Adherence tools and programs encourage patients to stay compliant with their treatment...

    Webinar: The patient journey: Time to look beyond the physician?

    Treatment initiation is a key focus for many pharma companies as part of their strategy to increase script writing and drive greater revenues.

    Webinar: Ensuring an actionable segmentation

    One of the most consistent issues researchers face with segmentation is ensuring that it is actionable.